Preparation and characterization of a new monoclonal antibody against CXCR4 using lentivirus vector
- 1 July 2016
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 36, 100-105
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (J1103604)
This publication has 20 references indexed in Scilit:
- Regulated Expression of Lentivirus-Mediated GDNF in Human Bone Marrow-Derived Mesenchymal Stem Cells and Its Neuroprotection on Dopaminergic Cells In VitroPLOS ONE, 2013
- Novel Approaches to Inhibit HIV EntryViruses, 2012
- Quantitative Phosphoproteomics of CXCL12 (SDF-1) SignalingPLOS ONE, 2011
- Immunization delivered by lentiviral vectors for cancer and infectious diseasesImmunological Reviews, 2010
- Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosisJournal of Experimental & Clinical Cancer Research, 2010
- Lentiviral Vectors in Gene Therapy: Their Current Status and Future PotentialArchivum Immunologiae et Therapiae Experimentalis, 2010
- Integrase-defective lentiviral vectors: progress and applicationsGene Therapy, 2009
- Characterization and Application of Two Novel Monoclonal Antibodies Against Human CXCR4: Cell Proliferation and Migration Regulation for Glioma Cell Line in vitro by CXCR4/SDF-1α SignalHybridoma, 2009
- Lentivirus Display: Stable Expression of Human Antibodies on the Surface of Human Cells and Virus ParticlesPLOS ONE, 2008
- Genomic organization and promoter characterization of human CXCR4 gene1FEBS Letters, 1998